Peptide Drug Design & Delivery Summit
The popularity of peptide therapeutics has increased significantly in recent years. It is estimated that by 2018, the global Peptide therapeutics market is expected to pass $25 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include high-throughput approaches. Conjugation technologies are also contributing to the growth of peptide therapeutics, and leading to innovative approaches to designing safe and effective therapies.